Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boxall

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal of Virological Methods|July 11, 2001
The diagnostic significance of an assay for 'total' hepatitis C core antigenJ B Kurtz, E Boxall, N Qusir, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell linesP Rogers, F E Boxall, C P Allott, et al.
World Journal of Urology|May 12, 2021
A call for HoLEP: AEEP for mega-prostates (≥ 200 cc)Nicholas E Boxall, Fanourios Georgiades, Saiful Miah, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell linesJ Holford, P J Beale, F E Boxall, et al.
Journal of Medical Virology|December 1, 1989
Epidemiology of human T-cell leukaemia/lymphoma virus type 1 (HTLV-1) infections in a subpopulation of Afro-Caribbean origin in EnglandJ Mowbray, S Mawson, A Chawira, et al.
QJM : Monthly Journal of the Association of Physicians|February 19, 2008
Ante-natal screening and post-natal follow-up of hepatitis B in the West Midlands of EnglandS Bhattacharya, K O'Donnell, T Dudley, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatinS Y Sharp, C F O'Neill, P Rogers, et al.
Transfusion Medicine (Oxford, England)|April 21, 2006
Transfusion-transmitted hepatitis E in a 'nonhyperendemic' countryE Boxall, A Herborn, G Kochethu, et al.
Anticancer Research|July 1, 1996
Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation productsF I Raynaud, F E Boxall, P Goddard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Carboplatin and etoposide pharmacokinetics in patients with testicular teratomaD R Newell, R A Eeles, L A Gumbrell, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Virological Methods|July 11, 2001
The diagnostic significance of an assay for 'total' hepatitis C core antigenJ B Kurtz, E Boxall, N Qusir, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell linesP Rogers, F E Boxall, C P Allott, et al.
World Journal of Urology|May 12, 2021
A call for HoLEP: AEEP for mega-prostates (≥ 200 cc)Nicholas E Boxall, Fanourios Georgiades, Saiful Miah, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell linesJ Holford, P J Beale, F E Boxall, et al.
Journal of Medical Virology|December 1, 1989
Epidemiology of human T-cell leukaemia/lymphoma virus type 1 (HTLV-1) infections in a subpopulation of Afro-Caribbean origin in EnglandJ Mowbray, S Mawson, A Chawira, et al.
QJM : Monthly Journal of the Association of Physicians|February 19, 2008
Ante-natal screening and post-natal follow-up of hepatitis B in the West Midlands of EnglandS Bhattacharya, K O'Donnell, T Dudley, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatinS Y Sharp, C F O'Neill, P Rogers, et al.
Transfusion Medicine (Oxford, England)|April 21, 2006
Transfusion-transmitted hepatitis E in a 'nonhyperendemic' countryE Boxall, A Herborn, G Kochethu, et al.
Anticancer Research|July 1, 1996
Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation productsF I Raynaud, F E Boxall, P Goddard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Carboplatin and etoposide pharmacokinetics in patients with testicular teratomaD R Newell, R A Eeles, L A Gumbrell, et al.
Pageof 5